SCHEMBL8486922

SCHEMBL8486922

Fc1ncccc1/C=C\c1cccnc1F

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ NAPRT Q6XQN6 1/20 0.48
▸ NFE2L2 Q16236 12/20 0.44
▸ KDM4E B2RXH2 3/20 0.42
▸ TRIM24 O15164 1/20 0.40
▸ TRIM33 Q9UPN9 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ GRM4 Q14833 1/20 0.38
▸ AMY1A P0DUB6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8486928 1.00 NAPRT (0.48) NAPRTNFE2L2KDM4ETRIM24TRIM33
SCHEMBL31095185 0.88 NFE2L2 (0.53) NAPRTNFE2L2KDM4ETRIM24TRIM33
SCHEMBL31095207 0.86 HSD11B1 (0.43) NAPRTNFE2L2KDM4ETRIM24TRIM33
SCHEMBL31095224 0.86 HSD11B1 (0.43) NAPRTNFE2L2KDM4ETRIM24TRIM33
SCHEMBL20959864 0.83 NPC1 (0.57) KDM4EMEN1NPC1RAB9AKMT2A
SCHEMBL30632983 0.82 NAPRT (0.36) NAPRTNFE2L2KDM4ETRIM24TRIM33
SCHEMBL16343065 0.81 — —
SCHEMBL29576848 0.81 — —
SCHEMBL7216964 0.81 — —
SCHEMBL172054 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5869482-A Dipyridio 2,3-b:3',2'-! azepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACUETICALS, INC. (US) 1999-02-09 — — US disclosed
WO-1998020002-A1 DIPYRIDO[2,3-B:3',2'-F]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-05-14 — — WO disclosed
Send feedback